The goal of this funding opportunity is to further support the rare disease research community. We know that having access to cutting-edge, innovative tools is critical in the development of novel therapeutics for rare diseases. This is why GemPharmatech is so dedicated to creating custom genetically modified mouse models (GEMMs). We are also committed to making these custom models more accessible to researchers. Therefore, in 2020 we launched the GEMMs for Rare Disease Research initiative. The aim of this initiative is to provide non-profit rare disease research organizations with custom GEMMs at a significantly reduced cost. Specifically, we will fund more than 85% of the costs associated with GEMM construction. We admire your dedication to rare disease research and are looking forward to learning more about your projects.